171 related articles for article (PubMed ID: 10096433)
1. Metabolism of carbamazepine by CYP3A6: a model for in vitro drug interactions studies.
Mesdjian E; Sérée E; Charvet B; Mirrione A; Bourgarel-Rey V; Desobry A; Barra Y
Life Sci; 1999; 64(10):827-35. PubMed ID: 10096433
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat.
Panesar SK; Bandiera SM; Abbott FS
Drug Metab Dispos; 1996 Jun; 24(6):619-27. PubMed ID: 8781776
[TBL] [Abstract][Full Text] [Related]
3. Differential selectivity in carbamazepine-induced inactivation of cytochrome P450 enzymes in rat and human liver.
Masubuchi Y; Nakano T; Ose A; Horie T
Arch Toxicol; 2001 Nov; 75(9):538-43. PubMed ID: 11760814
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 isozymes and antiepileptic drug interactions.
Levy RH
Epilepsia; 1995; 36 Suppl 5():S8-13. PubMed ID: 8806399
[TBL] [Abstract][Full Text] [Related]
5. Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients.
Ragueneau-Majlessi I; Levy RH; Bergen D; Garnett W; Rosenfeld W; Mather G; Shah J; Grundy JS
Epilepsy Res; 2004 Nov; 62(1):1-11. PubMed ID: 15519127
[TBL] [Abstract][Full Text] [Related]
6. Carbamazepine: a 'blind' assessment of CVP-associated metabolism and interactions in human liver-derived in vitro systems.
Pelkonen O; Myllynen P; Taavitsainen P; Boobis AR; Watts P; Lake BG; Price RJ; Renwick AB; Gómez-Lechón MJ; Castell JV; Ingelman-Sundberg M; Hidestrand M; Guillouzo A; Corcos L; Goldfarb PS; Lewis DF
Xenobiotica; 2001 Jun; 31(6):321-43. PubMed ID: 11513246
[TBL] [Abstract][Full Text] [Related]
7. CYP3A4 and CYP3A7-mediated carbamazepine 10,11-epoxidation are activated by differential endogenous steroids.
Nakamura H; Torimoto N; Ishii I; Ariyoshi N; Nakasa H; Ohmori S; Kitada M
Drug Metab Dispos; 2003 Apr; 31(4):432-8. PubMed ID: 12642469
[TBL] [Abstract][Full Text] [Related]
8. A mechanistic approach to antiepileptic drug interactions.
Anderson GD
Ann Pharmacother; 1998 May; 32(5):554-63. PubMed ID: 9606477
[TBL] [Abstract][Full Text] [Related]
9. Carbamazepine-Induced Liver Injury Requires CYP3A-Mediated Metabolism and Glutathione Depletion in Rats.
Iida A; Sasaki E; Yano A; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
Drug Metab Dispos; 2015 Jul; 43(7):958-68. PubMed ID: 25870103
[TBL] [Abstract][Full Text] [Related]
10. CYP3A inductive potential of the rifamycins, rifabutin and rifampin, in the rabbit.
Weber A; Kaplan M; Chughtai SA; Cohn LA; Smith AL; Unadkat JD
Biopharm Drug Dispos; 2001 May; 22(4):157-68. PubMed ID: 11745918
[TBL] [Abstract][Full Text] [Related]
11. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
[TBL] [Abstract][Full Text] [Related]
12. Carbamazepine and oxcarbazepine decrease phenytoin metabolism through inhibition of CYP2C19.
Lakehal F; Wurden CJ; Kalhorn TF; Levy RH
Epilepsy Res; 2002 Dec; 52(2):79-83. PubMed ID: 12458024
[TBL] [Abstract][Full Text] [Related]
13. Time-course of hepatic cytochrome p450 subfamily induction by chronic carbamazepine treatment in rats.
Yamashita H; Kazawa T; Minatogawa Y; Ebisawa T; Yamauchi T
Int J Neuropsychopharmacol; 2002 Mar; 5(1):47-52. PubMed ID: 12057031
[TBL] [Abstract][Full Text] [Related]
14. Effects of endogenous steroids on CYP3A4-mediated drug metabolism by human liver microsomes.
Nakamura H; Nakasa H; Ishii I; Ariyoshi N; Igarashi T; Ohmori S; Kitada M
Drug Metab Dispos; 2002 May; 30(5):534-40. PubMed ID: 11950784
[TBL] [Abstract][Full Text] [Related]
15. Studies on interactions between traditional herbal and Western medicines. IV: lack of pharmacokinetic interactions between Saiko-ka-ryukotsu-borei-to and carbamazepine in rats.
Ohnishi N; Nakasako S; Okada K; Umehara S; Takara K; Nagasawa K; Yoshioka M; Kuroda K; Yokoyama T
Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):129-35. PubMed ID: 11554427
[TBL] [Abstract][Full Text] [Related]
16. Interactions of phenobarbital and phenytoin with carbamazepine and its metabolites' concentrations, concentration ratios, and level/dose ratios in epileptic children.
Liu H; Delgado MR
Epilepsia; 1995 Mar; 36(3):249-54. PubMed ID: 7614908
[TBL] [Abstract][Full Text] [Related]
17. Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omeprazole, but has no or less effect on hydroxylation via CYP2C19.
Bertilsson L; Tybring G; Widén J; Chang M; Tomson T
Br J Clin Pharmacol; 1997 Aug; 44(2):186-9. PubMed ID: 9278208
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human cytochrome P450 isoenzymes involved in the metabolism of vinorelbine.
Beulz-Riché D; Grudé P; Puozzo C; Sautel F; Filaquier C; Riché C; Ratanasavanh D
Fundam Clin Pharmacol; 2005 Oct; 19(5):545-53. PubMed ID: 16176333
[TBL] [Abstract][Full Text] [Related]
19. Modulation of CYP3A enzyme activity by diosmin and its consequence on carbamazepine pharmacokinetics in rats.
Bedada SK; Neerati P
Naunyn Schmiedebergs Arch Pharmacol; 2018 Feb; 391(2):115-121. PubMed ID: 29134244
[TBL] [Abstract][Full Text] [Related]
20. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT
Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
